Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | PRKDC | P78527 | 5/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | ADK | P55263 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22893845 | 0.93 | ALOX5 (0.32) | ALOX5PRKDCPIK3CDPIK3CB | |
| SCHEMBL16785816 | 0.92 | ALOX5 (0.38) | ALOX5PRKDCPIK3CDPIK3CBATM | |
| SCHEMBL24030399 | 0.92 | ALOX5 (0.32) | ALOX5PRKDCPIK3CDPIK3CB | |
| SCHEMBL21716524 | 0.91 | ALOX5 (0.33) | ALOX5PRKDCPIK3CDPIK3CBHDAC8 | |
| SCHEMBL15583010 | 0.91 | ALOX5 (0.38) | ALOX5PRKDCPIK3CDPIK3CBATM | |
| SCHEMBL21716572 | 0.90 | ALOX5 (0.33) | ALOX5PRKDCPIK3CDPIK3CBHDAC8 | |
| SCHEMBL21213731 | 0.88 | ALOX5 (0.37) | ALOX5PRKDCPIK3CDPIK3CBATM | |
| SCHEMBL24030347 | 0.88 | ALOX5 (0.31) | ALOX5PRKDCPIK3CDPIK3CB | |
| SCHEMBL19653954 | 0.88 | KDM4E (0.35) | ALOX5PRKDCPIK3CDPIK3CBATM | |
| SCHEMBL16706423 | 0.87 | ALOX5 (0.38) | ALOX5PRKDCPIK3CDPIK3CBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220216433-A1 | ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-07-07 | — | — | US | disclosed |
| US-10971687-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-04-06 | — | — | US | disclosed |
| US-20210013411-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2021-01-14 | — | — | US | disclosed |
| US-20190189930-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220216433-A1 | ELECTROLUMINESCENT DEVICE | EML4, EMC2, L1CAM | ALOX5 4395/4885PRKDC 3716/4885PIK3CD 3921/4885 |
| US-10971687-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, XDH | ALOX5 737/4885PRKDC 4085/4885PIK3CD 3677/4885 |
| US-20190189930-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, XDH | ALOX5 737/4885PRKDC 4085/4885PIK3CD 3677/4885 |
| US-20210013411-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | ALOX5 660/4885PRKDC 4556/4885PIK3CD 4563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.